Powered by: Motilal Oswal
2023-10-25 10:03:55 am | Source: Accord Fintech
Piramal Enterprises shines on getting nod to raise upto Rs 800 crore through NCDs
Piramal Enterprises shines on getting nod to raise upto Rs 800 crore through NCDs

Piramal Enterprises is currently trading at Rs. 988.20, up by 20.50 points or 2.11% from its previous closing of Rs. 971.15 on the BSE.

The scrip opened at Rs. 980.00 and has touched a high and low of Rs. 992.00 and Rs. 975.95 respectively. So far 6521 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1140.00 on 11-Sep-2023 and a 52 week low of Rs. 630.20 on 28-Mar-2023.

Last one week high and low of the scrip stood at Rs. 1058.05 and Rs. 967.00 respectively. The current market cap of the company is Rs. 21818.22 crore.

The promoters holding in the company stood at 46.19%, while Institutions and Non-Institutions held 31.74% and 22.07% respectively.

Piramal Enterprises has received approval to raise upto Rs 800 crore through issuance of Secured, Rated, Unlisted, Redeemable Non-Convertible Debentures (Debentures) on private placement basis. The Meeting of Administrative Committee (‘Committee’) of the Board of Directors held on October 24, 2023 approved the same.  

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here